Pseudoprogression in patients with uterine leiomyosarcoma treated with first-line single-agent doxorubicin. - Howroyd LR; Cornell I; Benson C; Napolitano A; Blackledge M; Sumhonmun T; Moskovic E; Kelly-Morland C; Adejolu M; Jones RL; Messiou C (European journal of cancer (Oxford, England : 1990), 2023)